Guanine-rich oligonucleotide modified at the 5' terminal by dimethoxytrityl residue inhibits HIV-1 replication by specific interaction with the envelope glycoprotein

Antiviral Research

Volumn 31, Issue 3, 1996, Pages 137-148

  Agatsuma, Toshinori ^a   Yamamoto, Ikue ^a   Furukawa, Hidehiko ^a   Nishigaki, Takashi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Dimethoxytrityl oligomer; gp120; HIV 1; Oligonucleotide; V3 loop

Indexed keywords

ANTIVIRUS AGENT; GLYCOPROTEIN GP 120; OLIGONUCLEOTIDE;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030200369     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(96)00960-6     Document Type: Article

References (48)

1. Bennett, C.F., Chiang, M.Y., Wilson, L.L. and Wyatt, J.R. (1994) Sequence specific inhibition of human type II phospholipase A2 enzyme activity by phosphorothioate oligonucleotides. Nucleic Acids Res. 22, 3202-3209.
2. Buchacher, A., Predl, R., Tauer, C., Purtscher, M., Gruber, G., Heider, R., Steindl, F., Trkola, A., Jungbauer, A. and Katinger, H. (1992) Human monoclonal antibodies against gp41 and gp120 as potential agent for passive immunization. Vaccines 92, 191-195.
3. Buckheit, R.J., Roberson, J.L., Lackmann-Smith, C., Wyatt, J.R., Vickers, T.A. and Ecker, D.J. (1994) Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by a G quartet-forming oligonucleotide (ISIS5320). AIDS Res. Hum. Retroviruses 10, 1497-1506.
4. Burgess, T.L., Fisher, E.F., Ross, S.L., Bready, J.V., Qian, Y., Bayewitch, L.A., Cohen, A.M., Herrera, C.J., Hu, S.S., Kramer, T.B., Lott, F.D., Martin, F.H., Pierce, G.F., Simonet, L. and Farrell, C.L. (1995) The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. USA 92, 4051-4055.
5. Callebaut, C., Krust, B., Jacotot, E. and Hovanessian, A.G. (1993) T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells. Science 262, 2045-2050.
6. Clements, G.J., Price-Jones M.J., Stephens. P.E., Sutton, C., Schulz, T.F., Clapham, P.R., McKeating, J.A., McClure, M.O., Thomson, S., Marsh, M., Kay, J., Weiss, R.A. and Moore, J.P. (1992) The V3 loop of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Res. Hum. Retroviruses 7, 3-16.
7. Cordell, J., Moore, J.P., Dean, C.J., Klasse, P.J., Weiss, R.A. and McKeating, J.A. (1991) Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in vitro. Virology 185, 72-79.
8. Dalgleish, A.G., Beverly, P.C.L., Clapham, P.R., Crawford, D.H., Greaves, M.F. and Weiss, R.A. (1984) The CD4 (T4) antigen is an essential component of the receptor for AIDS retrovirus. Nature 312, 763-766.
9. Dash, P. Lotan, I., Knapp, M., Kandel, E. R. and Goelet, P. (1987) Selective elimination of mRNAs in vivo: complementary oligonucleotides promote RNA degradation by an RNase H-like activity. Proc. Natl. Acad. Sci. USA 84, 7896-7900.
10. Fecondo, J.V., Pavuk, N.C., Silburn, K.A., Read, D.M., Mansell, A.S., Boyd, A.W. and McPhee, D.A. (1993) Synthetic peptide analogs of intercellular adhesion molecule 1 (ICAM-1) inhibit HIV-1 replication in MT-2 cells. AIDS Res. Hum. Retroviruses 9, 733-740.
11. Fennewald, S.M., Mustain, S., Ojwang, J. and Rando, R.F. (1995) Inhibition of herpes simplex virus in culture by oligonucleotides composed entirely of deoxyguanosine and thymidine. Antiviral Res. 26, 37-54.
12. Freed, E.O., Myers, D.J. and Risser, R. (1990) Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl. Acad. Sci. USA 87, 4650-4654.
13. Furukawa, H., Momota, K., Agatsuma, T. and Yamamoto, Y. (1994) Mechanism of inhibition of HIV-1 infection in vitro by guanine-rich oligonucleotides modified at the 5′ terminal by dimethoxytrityl residue. Nucleic Acids Res. 22, 5621-5627.
14. Ghiara, J.B., Stura, E.A., Stanfield, R.L., Profy, A.T. and Wilson, I.A. (1994) Crystal structure of the principal neutralization site of HIV-1. Science 264, 82-85.
15. Gorny, M.K., Conley, A.J., Karwowska, S., Buchbinder, A., Xu, J.Y., Emini, E.A., Koenig, S. and Zolla, P.S. (1992) Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J. Virol. 66, 7538-7542.
16. Gruber, M.F., Webb, D.S., Gerrard, T. L., Mostowski, H.S., Vujcic, L. and Golding, H. (1991) Re-evaluation of the involvement of the adhesion molecules ICAM-1/ LFA-1 in syncytia formation of HIV-1-infected subclones of a CEM T-cell leukemic line. AIDS Res. Hum. Retroviruses 7, 45-53.
17. Harrop, H.A., Coombe, D.R. and Rider, C.C. (1994) Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding. AIDS 8, 183-192.
18. Helseth, E., Olshevsky, U., Gabuzda, D., Ardam, B., Haseltine, W. and Sodoroski, J. (1990) Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion. J. Virol. 64, 6314-6318.
19. Hildreth, J.E. and Orentas, R.J. (1989) Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 244, 1075-1078.
20. Hotoda, H., Momota, K., Furukawa, H., Nakamura, T. and Kaneko, M. (1994) Biologically active oligodeoxyribonucleotides-II: structure activity relationships of anti-HIV-1 pentadecadeoxyribonucleotides bearing 5′-end-modifications. Nucleosides and Nucleotides 13, 1375-1395.
21. Javaherian, K., Langlois, A.J., LaRosa, G.J., Profy, A.T., Bolognesi, D.P., Herlihy, W.C., Putney, S.D. and Matthews, T.J. (1990) Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. Science 250, 1590-1593.
22. Kang, C.Y., Nara, P., Chamat, S., Caralli, V., Ryskamp, T., Haigwood, N., Newman, R. and Kohler, H. (1991) Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans. Proc. Natl. Acad. Sci. USA 88, 6171-6175.
23. LaRosa, G.J., Davide, J.P., Weinhold, K., Waterbury, J.A., Profy, A.T., Lewis, J.A., Langlois, A.J., Dreesman, G.R., Boswell, R.N., Shadduck, P., Holley, L.H., Karplus, M., Bolognesi, D.P., Matthews, T.J., Emini, E.A. and Putney, S.D. (1990) Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 249, 932-935.
24. Lederman, S., Gulick, R. and Chess, L. (1989) Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV. J. Immunol. 143, 1149-1154.
25. Linsley, P.S., Ledbetter, J.A., Kinney-Thomas E. and Hu, S.L. (1988) Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the Env protein of human immunodeficiency virus type 1. J. Virol. 62, 3695-3702.
26. Majumdar, C., Stein, C.A., Cohen, J.S., Broder, S. and Wilson, S.H. (1989) Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide. Biochemistry 28, 1340-1346.
27. Marshall, W.S., Beaton, G., Stein, C.A., Matsukura, M. and Caruthers, M.H. (1992) Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine. Proc. Natl. Acad. Sci. USA 89, 6265-6269.
28. Matsukura, M., Shinozuka, K., Zon, G., Mitsuya, H., Reitz, M., Cohen, J.S. and Broder, S. (1987) Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 84, 7706-7710.
29. Matthew, T.J., Wild, C., Chen, C., Bolognesi, D. and Greenberg, M.L. (1994) Structural rearrangements in the transmembrane glycoprotein after receptor binding. Immunol. Rev. 140, 93-104.
30. McKeating, J.A., Cordell, J., Dean, C.J.and Balfe, P. (1992a) Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120. Virology 191, 732-742.
31. McKeating, J.A., Thali, M., Furman, C., Karwowska, S., Gorny, M.K., Cordell, J., Zolla. P.S., Sodroski, J. and Weiss, R.A. (1992b) Amino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction. Virology 190, 134-142.
32. McKeating, J.A., Shotton, C., Cordell, J., Graham, S., Balfe, P., Sullivan, N., Charles, M., Page, M., Bolmstedt, A., Olofsson, S., Kayman, S.C., Wu, Z., Pinter, A., Dean, C., Sodroski, J. and Weiss, R.A. (1993) Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120. J. Virol. 67, 4932-4944.
33. Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Ruker, F. and Katinger, H. (1993) A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67, 6642-6647.
34. Ohno, T., Terada, M., Yoneda, Y., Shea, K.W., Chambers, R.F., Stroka, D.M., Nakamura, M. and Kufe, D.W. (1991) A broadly neutralizing monoclonal antibody that recognizes the V3 region of human immunodeficiency virus type 1 glycoprotein gp120. Proc. Natl. Acad. Sci. USA 88, 10726-10729.
35. Ojwang, J., Elbaggari, A., Marshall, H. B., Jayaraman, K., McGrath, M.S. and Rando, R.F. (1994) Inhibition of human immunodeficiency virus type 1 activity in vitro by oligonucleotides composed entirely of guanosine and thymidine. J. Acquir. Immune. Defic. Syndr. 7, 560-570.
36. Ojwang, J.O., Buckheit, R.W., Pommier, Y., Mazumder, A., Devreese, K., Este, J.A., Reymen, D., Pallansch, L.A., Lackmansmith, C., Wallace, T.L., De Clercq, E., Mcgrath, M.S. and Rando R.F. (1995) T30177, an oligonucleotide stabilized by an intramolecular guanosine octes, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus. Antimicrob. Agents Chemother. 39, 2426-2435.
37. Rando, R.F., Ojwang, J., Elbaggari, A., Reyes, G.R., Tinder, R., McGrath, M.S. and Hogan, M.E. (1995) Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular tetrads. J. Biol. Chem. 270, 1754-1760.
38. Sattentau, Q.J. and Moore, J.P. (1991) Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174, 407-415.
39. Schols, D., Baba, M., Pauwels, R., Desmyter, J. and De Clercq, E. (1989) Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. Proc. Natl. Acad. Sci. USA 86, 3322-3326.
40. Schols, D., Pauwels, R., Desmyter, J. and De Clercq, E. (1990) Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. Virology 175, 556-561.
41. Skinner, M.A., Langlois, A.J., McDanal, C.B., McDougal, J.S., Bolognesi, D.P. and Matthews, T.J. (1988) Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. J. Virol. 62, 4195-4200.
42. Smith, F.W., Lau, F.W. and Feigon, J. (1994) d(G3T4G3) forms an asymmetric diagonally looped dimeric quadruplex with guanosine 5′-syn-syn-anti and 5′-syn-anti-anti N-glycosidic conformations. Proc. Natl. Acad. Sci. USA 91, 10546-10550.
43. Steimer, K.S., Scandella, C.J., Skiles, P.V. and Haigwood, N.L. (1991) Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to gp120. Science 254, 105-108.
44. Stein, C.A., Neckers, L.M., Nair, B.C., Mumbauer, S., Hoke, G. and Pal, R. (1991) Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4. J. Acquir. Immune. Defic. Syndr. 4, 686-693.
45. Stein, C.A., Cleary, A.M., Yakubov, L. and Lederman, S. (1993) Phosphorothioate oligodeoxynucleotides bind to the third variable loop domain (V3) of human immunodeficiency virus type 1 gp120. Antisense. Res. Dev. 3, 19-31.
46. Valentin, A., Lundin, K., Patarroyo, M. and Asjo, B. (1990) The leukocyte adhesion glycoprotein CD18 participates in HIV-1-induced syncytia formation in monocytoid and T cells. J. Immunol. 144, 934-937.
47. Wyatt, J.R., Vickers, T.A., Roberson, J.L., Buckheit, R.W., Klimkait, T., DeBaets, E., Davis, P.W., Rayner, B., Imbach, J.L. and Ecker, D.J. (1994). Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc. Natl. Acad. Sci. USA 91, 1356-1360.
48. Yaswen, P., Stampfer, M.R., Ghosh, K. and Cohen, J.S. (1993) Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Antisense Res. Dev. 3, 67-77.